Myriad Presents Fourth Study Showing Prolaris Score Predicts Prostate Cancer Aggressiveness
February 08, 2012
Myriad Presents Fourth Study Showing Prolaris Score Predicts Prostate Cancer Aggressiveness
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Prospective Validation Confirms Sensitivity of Veracyte's Gene Expression Test for Thyroid Nodule Risk
June 27, 2012 / Pharmacogenomics Reporter - Canadian Team Says Four-Gene Signature Could Predict Oral Cancer Recurrence, Improve on Histology
October 19, 2011 / Pharmacogenomics Reporter - Prostate Cancer Risk Markers Show Promise for Test to ID Elevated Risk in Men with Benign Hyperplasia
April 3, 2013 / Pharmacogenomics Reporter - Medicare Administrator Issues Draft Decision Adding Myriad's Prolaris Test to Non-covered Service
September 24, 2012 / GenomeWeb Daily News - CardioDx Says $58M Financing Will Support Commercial Expansion Following Medicare Coverage Win
August 29, 2012 / Pharmacogenomics Reporter